title: Effects of physician-related factors on adult asthma care, health status, and quality of life.
abstract: OBJECTIVE
  To study the association of physician characteristics, the characteristics of their practice settings, patient mix, and reported frequency of prescribing asthma medication with patients' health status and health-related quality of life in asthma.
  
  
  METHODS
  We conducted a mail-back survey of physicians (n = 147) that included demographic characteristics, practice and training characteristics, and reported prescribing frequencies for common asthma treatments. We also conducted structured telephone interviews with 317 of their patients, assessing demographic characteristics, health status (as measured by the Short Form-12 [SF-12] physical component score), and asthma-specific quality of life (as measured by the Marks questionnaire).
  
  
  RESULTS
  In adjusted analyses, pulmonary specialists were more likely to report using leukotriene modifiers (odds ratio [OR] = 4.7; 95% confidence interval [CI]: 1.2 to 18) and theophylline (OR = 3.0; 95% CI: 1.0 to 9.0) in adult patients with asthma. Working in a practice of >75% health maintenance organization (HMO)- or preferred provider organization (PPO)-insured patients was associated with a lower likelihood of prescribing leukotriene modifiers (OR = 0.1; 95% CI: 0.01 to 0.5). Adjusting for patient demographic characteristics and steroid dependence, physician prescribing tendencies were not associated with patients' perceived health status or quality of life. Although an HMO- or PPO-predominant practice was associated with better physical health status (mean difference in SF-12 physical component score, 3.1; 95% CI: 0.05 to 6.2; P = 0.05), there was no statistical association with quality of life.
  
  
  CONCLUSIONS
  The characteristics of physicians, their practices, and the asthma medication prescribing strategies that they adopt are not strongly associated with patients' perceived outcomes.
authors.affiliation: Division of Occupational and Environmental Medicine, Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco 94117, USA. blancp@itsa.ucsf.edu
authors.forename: Paul D
authors.initials: PD
authors.lastname: Blanc
authors.forename: Laura
authors.initials: L
authors.lastname: Trupin
authors.forename: Gillian
authors.initials: G
authors.lastname: Earnest
authors.forename: Melanie
authors.initials: M
authors.lastname: San Pedro
authors.forename: Patricia P
authors.initials: PP
authors.lastname: Katz
authors.forename: Edward H
authors.initials: EH
authors.lastname: Yelin
authors.forename: Mark D
authors.initials: MD
authors.lastname: Eisner
mesh_terms: D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D002983:Clinical Competence / Q000706:statistics & numerical data; D005260:Female; D019538:Health Care Surveys / Q000706:statistics & numerical data; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data; D010819:Physician's Role; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011364:Professional Practice / Q000706:statistics & numerical data*; D011788:Quality of Life; D012720:Severity of Illness Index
chemical_list: D018927:Anti-Asthmatic Agents